» Articles » PMID: 31168178

PRO-OXIDANTS AND ANTIOXIDANTS IN RETINOPATHY OF PREMATURITY

Overview
Journal Acta Clin Croat
Specialty General Medicine
Date 2019 Jun 7
PMID 31168178
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

- Premature infants are susceptible to oxidative stress that causes neonatal disease such as retinopathy of prematurity (ROP). Oxidative stress is an imbalance between the production of pro-oxidants and the ability of the body to detoxify their harmful effects by antioxidants. The proliferative phase 2 ROP occurs at around 33 postmenstrual week (pmw). The purpose of our study was to evaluate the pro-oxidant/antioxidant status in preterm infants at 33 pmw. The study included 59 premature infants. ROP was classified according to the International Classification of Retinopathy of Prematurity. Total oxidative status (TOS), total antioxidant status (TAS), malondialdehyde (MDA) and paraoxonase 1 (PON1) activity were determined spectrophotometrically. The values of the pro-oxidants TOS and MDA were significantly higher in infants with ROP as compared to infants without ROP (p<0.05 both). There were no significant differences in the values of TAS and PON1 between the infants with and without ROP. According to study results, TOS and MDA are good markers of oxidative stress, whereas TAS and PON1 activity are unreliable in assessing antioxidant protection.

Citing Articles

Retinopathy of Prematurity in Eight Portuguese Neonatal Intensive Care Units: Incidence, Risk Factors, and Progression-A Prospective Multicenter Study.

Fevereiro-Martins M, Santos A, Marques-Neves C, Bicho M, Guimaraes H, The GenE-Rop Study Group Children (Basel). 2024; 11(10).

PMID: 39457121 PMC: 11505647. DOI: 10.3390/children11101154.


The Role of HIF-1α in Retinopathy of Prematurity: A Review of Current Literature.

Modrzejewska M, Zdanowska O, Polubinski P J Clin Med. 2024; 13(14).

PMID: 39064074 PMC: 11277540. DOI: 10.3390/jcm13144034.


Oxidative stress in the eye and its role in the pathophysiology of ocular diseases.

Bohm E, Buonfiglio F, Voigt A, Bachmann P, Safi T, Pfeiffer N Redox Biol. 2023; 68:102967.

PMID: 38006824 PMC: 10701459. DOI: 10.1016/j.redox.2023.102967.


Oxygen for the Newborn: Friend or Foe?.

Perrone S, Manti S, Petrolini C, DellOrto V, Boscarino G, Ceccotti C Children (Basel). 2023; 10(3).

PMID: 36980137 PMC: 10047080. DOI: 10.3390/children10030579.


Retinopathy of prematurity: Metabolic risk factors.

Fu Z, Nilsson A, Hellstrom A, Smith L Elife. 2022; 11.

PMID: 36420952 PMC: 9691009. DOI: 10.7554/eLife.80550.


References
1.
Seiberth V, Linderkamp O . Risk factors in retinopathy of prematurity. a multivariate statistical analysis. Ophthalmologica. 2000; 214(2):131-5. DOI: 10.1159/000027482. View

2.
Hellstrom A, Perruzzi C, Ju M, Engstrom E, Hard A, Liu J . Low IGF-I suppresses VEGF-survival signaling in retinal endothelial cells: direct correlation with clinical retinopathy of prematurity. Proc Natl Acad Sci U S A. 2001; 98(10):5804-8. PMC: 33294. DOI: 10.1073/pnas.101113998. View

3.
Sozmen E, Sozmen B, Girgin F, Delen Y, Azarsiz E, Erdener D . Antioxidant enzymes and paraoxonase show a co-activity in preserving low-density lipoprotein from oxidation. Clin Exp Med. 2002; 1(4):195-9. DOI: 10.1007/s102380100003. View

4.
Weinberger B, Laskin D, Heck D, Laskin J . Oxygen toxicity in premature infants. Toxicol Appl Pharmacol. 2002; 181(1):60-7. DOI: 10.1006/taap.2002.9387. View

5.
Buonocore G, Perrone S, Longini M, Vezzosi P, Marzocchi B, Paffetti P . Oxidative stress in preterm neonates at birth and on the seventh day of life. Pediatr Res. 2002; 52(1):46-9. DOI: 10.1203/00006450-200207000-00010. View